Home » Newsletters » BioWorld Science

BioWorld Science

March 29, 2007

View Archived Issues

Snapshots on new candidates to reduce Abeta pathology in AD

Studies in vivo and in healthy volunteers support investigation of AT-2101

Snapshots: studies from the American College of Cardiology annual meeting

PRT-060128 well tolerated, well absorbed in phase I study

Recent patents describe new treatment options for diabetes

Novel antimitotics targeting the kinesin spindle protein presented at the ACS

Novel therapeutic agents for cardiovascular disorders reported in recent patent literature

Nesiritide study provides new renal and mortality safety data

Interim data suggest Nebido trial will meet endpoints

GSK's novel clinical candidate for the treatment of hepatitis C profiled at the ACS meeting

Tekturna and Diovan in combination produce improved blood pressure reduction

Recent Banyu and Lilly patents disclose novel antiobesity agents

Pramiconazole demonstrates efficacy in tinea versicolor

VEGF Trap-Eye improves retinal thickness and visual acuity in wet AMD

Weekly PC-DAC:Exendin-4 lowers blood glucose in type 2 diabetes

New data on gonadotropin-releasing hormone receptor blockers presented

Eltrombopag increases platelet counts in idiopathic thrombocytopenic purpura

OncoGel studied in phase I/II GBM study

Inovio's DNA delivery technology enhances potency of HIV DNA vaccine

FDA approves product enhancements for BeneFIX coagulation factor IX

Preclinical data for deCODE's DG-051 reported at the ACS meeting

Terameprocol studied in phase I/II trial for brain tumors

SSA-426: a novel antidepressant with dual activity on the 5-HT transporter and the 5-HT1A receptor

Resverlogix advances IND preparations for RVX-208

Botox to be studied for paroxysmal trigeminal neuralgia pain

rNAPc2 receives fast track designations in metastatic colorectal cancer

Preliminary phase III plan outlined for faropenem

Polyphenon E Ointment filed in European countries

Avastin approved in E.U. for first-line metastatic breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...